UCB's Global Corporate Website

Leading the way in R&D investment

Posted by
Xavier Hormaechea, Public Affairs
We view research spending as an investment rather than a cost. Our experience tells us that R&D sows the seeds for future growth, delivering the innovative medicines patients need.

After all, being Inspired by Patients. Driven by Science means looking to the lab for the new therapies that will become the future of our company.

We are living up to our promise to patients by investing heavily in innovation through partnerships with universities and commercial collaborations, along with building our new bioplant and supporting the next generation of scientists.

The latest EU Industrial R&D Investment Scoreboard shows UCB’s strong commitment to innovation, ranking the company as the number 1 R&D investor in Belgium.

With €782 million invested worldwide in R&D in 2012, UCB topped the table of Belgian companies investing in research and development. This figure is up more than 5% over the past three years and places us at number 44 in Europe and 145 in the world ranking.

Get the data here, or contact us if you have any questions.

Read: Investing in the future of science

Leave a Comment

By submitting your personal data, you agree with UCB's Data Privacy Policy. Furthermore, for more information on the terms of use of this website please visit our Legal Notice, accessible here.


Enter the characters shown in the image.